How much funding has AI/ML Innovations Inc. raised?

AI/ML Innovations Inc. has raised $6.67M in total funding. Their latest funding round was Debt. Key investors include Not Publicly Disclosed.

Where is AI/ML Innovations Inc. headquartered?

AI/ML Innovations Inc. is headquartered in Vancouver, Canada. The company has a team of 11-50 people.

What does AI/ML Innovations Inc. do?

AI/ML Innovations Inc. operates in the AI in Healthcare sector. A company focused on acquiring and advancing Artificial Intelligence and Machine Learning technologies, primarily targeting the digital healthcare sector. To provide transformative healthcare management solutions and precision support delivery across the health continuum by leveraging AI/ML, cloud computing, and digital platforms to enhance recovery outcomes and promote healthy living.

When was AI/ML Innovations Inc. founded?

AI/ML Innovations Inc. was founded in 2019. It is based in Vancouver, Canada.

How much funding has AI/ML Innovations Inc. raised?

AI/ML Innovations Inc. has raised $6.67M in total funding. Key investors include Not Publicly Disclosed.

Who is the CEO of AI/ML Innovations Inc.?

Paul Duffy is the CEO of AI/ML Innovations Inc.. The company was founded in 2019.

Where is AI/ML Innovations Inc. located?

AI/ML Innovations Inc. is headquartered in Vancouver, Canada.

What funding stage is AI/ML Innovations Inc. at?

AI/ML Innovations Inc. is currently at the Public stage.

How many employees does AI/ML Innovations Inc. have?

AI/ML Innovations Inc. has approximately 11-50 employees.

AI/ML Innovations Inc.

Category: AI in Healthcare

A company focused on acquiring and advancing Artificial Intelligence and Machine Learning technologies, primarily targeting the digital healthcare sector. AI/ML Innovations Inc. was founded in 2019. The company is led by Paul Duffy. Based in Vancouver, Canada. Team size: 11-50. Total funding raised: $6.67M. Latest round: Debt. Key investors include Not Publicly Disclosed.

Founded: 2019
Headquarters: Vancouver, Canada
Team size: 11-50
Total funding: $6.67M

Value proposition

To provide transformative healthcare management solutions and precision support delivery across the health continuum by leveraging AI/ML, cloud computing, and digital platforms to enhance recovery outcomes and promote healthy living.

Products and solutions

Health Gauge: A personal health monitoring and management system., Tech2Health: Digital health software and wearable technologies., General health-tech products and solutions.

Unique value

The company's strategy is to identify and acquire emerging digital health and wellness companies that utilize AI and ML, then foster their growth and development to build a portfolio of innovative healthcare solutions.

Target customer

Healthcare providers, caregivers, patients, and healthcare professionals.

Industries served

Digital Health, Healthcare AI, Telemedicine

Technology advantage

Leveraging AI and machine learning neural networks for non-invasive medicine and personal health monitoring. Business advantage resides in strategic acquisitions and partnerships enabling rapid integration and scaling of innovative technologies.

How they differentiate

AI/ML Innovations Inc. operates as a strategic acquirer and incubator of companies in the AI/ML sector, focusing on synergistic AI-driven healthcare technologies rather than a single product.

Main competitors

Fitbit (Google), Garmin, Teladoc Health

Key partnerships

Health Gauge (Subsidiary), Tech2Health (Subsidiary), NeuralCloud Solutions Inc. (Subsidiary), Lakeshore Cardiology (Commercial Term Sheet, Dec 2025, CardioYield deployment), Equimetrics (Commercial Term Sheet, Nov 2025, equine cardiac monitoring), European digital cardiac monitoring platform (Reseller Agreement, Mar 2026)

Notable customers

Lakeshore Cardiology (Commercial Term Sheet for CardioYield™ AI Holter analysis, Dec 2025), Equimetrics (Commercial Term Sheet for MaxYield™/CardioYield™ equine cardiac monitoring, Nov 2025), European digital cardiac monitoring platform (Reseller Agreement, Mar 2026), Partnerships with US-based healthcare and senior living providers (Tech2Health subsidiary).

Major milestones

Acquisition of key technology subsidiaries Health Gauge and Tech2Health., Listing on the Canadian Securities Exchange (CSE) under ticker AIML., Completed $1.55M private placement in 2024 to fund growth., Expansion of digital health platforms with pilot programs and partnerships in US healthcare sector.

Growth metrics

As a publicly traded company, stock performance is a public metric; specific revenue or user metrics for subsidiaries are not consistently disclosed.

Market positioning

Positions as a publicly-traded investment vehicle (CSE: AIML) providing access to a curated portfolio of early-stage ventures in digital health and AI/ML markets, focusing on commercialization and scaling.

Geographic focus

Primarily North America, headquartered in Vancouver, with a strategic focus on the large US healthcare market.

Patents and IP

Patents pending for personal health monitoring and management systems developed by subsidiary Health Gauge. Subsidiary NeuralCloud Solutions Inc. holds granted U.S. Patent No. 12,622,625 B2 (ECG/cardiac signal-processing, class A61B 5/346; inventors include John Paul Duffy and Esmatullah Naikyar) and has obtained ISO 13485:2016 certification.

About Paul Duffy

Over 30 years of leadership experience in digital technologies, with a strong background in the commercialization of AI, AR, and hologram technologies. Previously, he was President and Chairman of NexTech3D.AI and Co-founder and CEO of ARHT Media Inc.

Latest news about AI/ML Innovations Inc.

ThreeD Capital boosted its stake in AI/ML Innovations to ~38% (partially diluted) by acquiring a $450K convertible debenture, granting rights to 9M shares and 9M warrants. This raises ThreeD’s influen

More AI in Healthcare companies

Official website: https://www.aiml.health/